SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-16-152459
Filing Date
2016-11-30
Accepted
2016-11-30 16:14:05
Documents
1
Period of Report
2016-11-21

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3599
  Complete submission text file 0001209191-16-152459.txt   5475
Mailing Address BUILDING 227, TETRICUS SCIENCE PARK PORTON DOWN SALISBURY, WILTSHIRE X0 SP4 0JQ
Business Address BUILDING 227, TETRICUS SCIENCE PARK PORTON DOWN SALISBURY, WILTSHIRE X0 SP4 0JQ 44 0 1980 753002
KalVista Pharmaceuticals, Inc. (Issuer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | Fiscal Year End: 0430
SIC: 2834 Pharmaceutical Preparations

Mailing Address TUBORG HAVNEVEJ 19 HELLERUP G7 2900
Business Address TUBORG HAVNEVEJ 19 HELLERUP G7 2900 45 8824 8824
Novo A/S (Reporting) CIK: 0001388325 (see all company filings)

State of Incorp.: G7 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36830 | Film No.: 162025443